2
2021-06-04 L10819 N10819 H10819 WBC 10 9 /L 2.89 0.56 6.82 1.26 15.7 3.1 NEU 10 9 /L 1.31 0.27 3.25 0.64 7.96 1.60 %N 45.5 6.0 47.7 5.0 50.7 6.0 LYM 10 9 /L 0.85 0.20 1.74 0.50 3.35 1.00 %L 29.3 8.0 25.6 6.0 21.3 5.0 MONO 10 9 /L 0.31 0.20 0.77 0.40 1.87 0.60 %M 10.7 6.0 11.3 5.0 11.9 3.0 EOS 10 9 /L 0.10 0.10 0.18 0.17 0.48 0.19 %E 3.00 3.00 2.58 2.00 3.05 1.00 BASO 10 9 /L 0.10 0.10 0.25 0.25 0.50 0.50 %B 1.50 1.50 1.50 1.50 1.50 1.50 RBC 10 12 /L 2.81 0.25 4.25 0.39 5.17 0.83 HGB g/dL 7.46 0.30 11.8 0.5 16.3 0.8 HCT % 23.5 3.4 36.2 5.4 47.7 11.8 MCV fL 83.6 7.0 85.2 7.5 92.3 9.2 MCH pg 26.5 2.6 27.8 2.6 31.5 4.9 MCHC g/dL 31.7 4.9 32.7 5.0 34.2 7.8 RDW % 17.0 2.5 16.4 2.5 15.7 2.5 NRBC 10 9 /L* 0.01 0.01 0.01 0.01 2.20 0.60 NR/W* 0.20 0.20 0.08 0.08 14.0 2.5 PLT 10 9 /L 71.1 20.0 217 50 469 62 MPV fL 7.05 2.00 7.08 2.00 7.09 2.00 RETIC 10 9 /L 233 50 167 50 131 50 %R 8.31 1.50 3.92 1.00 2.54 0.80 IRF 0.64 0.18 0.52 0.14 0.32 0.10 IG 10 9 /L 0.32 0.11 0.81 0.22 1.89 0.43 %IG 11.2 3.4 11.9 3.0 12.0 2.2 %rP 9.72 2.00 8.89 1.70 9.14 1.60 MCHr pg 26.3 2.7 28.9 3.3 35.6 4.2

2021-06-04 L10819 N10819 H10819products.abbott.co.jp/medical/product/add2/AssaySheet/...kao NRBC negativna kontrola. Razina H je NRBC pozitivna kontrola. Raspon ne predstavlja standardne

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 2021-06-04 L10819 N10819 H10819products.abbott.co.jp/medical/product/add2/AssaySheet/...kao NRBC negativna kontrola. Razina H je NRBC pozitivna kontrola. Raspon ne predstavlja standardne

2021-06-04

L10819 N10819 H10819

WBC 109/L 2.89 0.56 6.82 1.26 15.7 3.1

NEU 109/L 1.31 0.27 3.25 0.64 7.96 1.60

%N 45.5 6.0 47.7 5.0 50.7 6.0

LYM 109/L 0.85 0.20 1.74 0.50 3.35 1.00

%L 29.3 8.0 25.6 6.0 21.3 5.0

MONO 109/L 0.31 0.20 0.77 0.40 1.87 0.60

%M 10.7 6.0 11.3 5.0 11.9 3.0

EOS 109/L 0.10 0.10 0.18 0.17 0.48 0.19

%E 3.00 3.00 2.58 2.00 3.05 1.00

BASO 109/L 0.10 0.10 0.25 0.25 0.50 0.50

%B 1.50 1.50 1.50 1.50 1.50 1.50

RBC 1012/L 2.81 0.25 4.25 0.39 5.17 0.83

HGB g/dL 7.46 0.30 11.8 0.5 16.3 0.8

HCT % 23.5 3.4 36.2 5.4 47.7 11.8

MCV fL 83.6 7.0 85.2 7.5 92.3 9.2

MCH pg 26.5 2.6 27.8 2.6 31.5 4.9

MCHC g/dL 31.7 4.9 32.7 5.0 34.2 7.8

RDW % 17.0 2.5 16.4 2.5 15.7 2.5

NRBC 109/L* 0.01 0.01 0.01 0.01 2.20 0.60

NR/W* 0.20 0.20 0.08 0.08 14.0 2.5

PLT 109/L 71.1 20.0 217 50 469 62

MPV fL 7.05 2.00 7.08 2.00 7.09 2.00

RETIC 109/L 233 50 167 50 131 50

%R 8.31 1.50 3.92 1.00 2.54 0.80

IRF 0.64 0.18 0.52 0.14 0.32 0.10

IG 109/L 0.32 0.11 0.81 0.22 1.89 0.43

%IG 11.2 3.4 11.9 3.0 12.0 2.2

%rP 9.72 2.00 8.89 1.70 9.14 1.60

MCHr pg 26.3 2.7 28.9 3.3 35.6 4.2

Page 2: 2021-06-04 L10819 N10819 H10819products.abbott.co.jp/medical/product/add2/AssaySheet/...kao NRBC negativna kontrola. Razina H je NRBC pozitivna kontrola. Raspon ne predstavlja standardne